Judith Dunn

Insider Reports History

Entity
Individual
Location
C/O Seelos Therapeutics, Inc., 300 Park Avenue, 12 Th Floor, New York, NY
Signature
/s/ William Cowles, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Judith Dunn:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Fulcrum Therapeutics, Inc. President, Research & Development Stock Option (right to buy) 141K Jan 19, 2022 Direct
Eliem Therapeutics, Inc. Director Stock Option (Right To Buy) 10K Jun 26, 2024 Direct

Insider Reports Filed by Judith Dunn

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELYM Eliem Therapeutics, Inc. Jun 26, 2024 1 $0 4 Jun 28, 2024 Director
ELYM Eliem Therapeutics, Inc. May 18, 2023 1 $0 4 May 22, 2023 Director
ELYM Eliem Therapeutics, Inc. May 19, 2022 1 $0 4 Jun 1, 2022 Director
FULC Fulcrum Therapeutics, Inc. Jan 19, 2022 1 $0 4 Jan 21, 2022 President, Research & Development
ELYM Eliem Therapeutics, Inc. Aug 9, 2021 0 $0 3 Aug 9, 2021 Director